IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

University of Notre Dame DU LAC

Q4 2023 Holdings

Filed 2024-02-13 | 2 holdings | $97.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$85.3M239,03187.3%
Spyre Therapeutics Inc(SYRE)COM00773J202$12.4M577,61612.7%